Australia recognises Sinovac, Covishield and Janssen vaccines

International students who are vaccinated with the Coronavac (Sinovac), Covishield (AstraZeneca/Serum Institute of India) and Janssen COVID-19 vaccines in their home countries will be able to re-enter Australia when travel restrictions are eased.

21 Oct 2021

International students who are vaccinated with the Coronavac (Sinovac), Covishield (AstraZeneca/Serum Institute of India) and Janssen COVID-19 vaccines in their home countries will be able to re-enter Australia when travel restrictions are eased.

Australia’s Therapeutic Goods Administration (TGA) has recognised the two additional vaccines as acceptable and safe for students who are currently overseas, but planning to return to Australia. You can read more in the Australian Prime Minister’s media statement here.

Declaring the two vaccines as safe for return travellers in the first instance, is a separate decision to whether they are approved for use in Australia – at this stage they won’t be added to the vaccine offerings available to students who are already in Australia.

We know that returning to face-to-face learning has been long-awaited by many students and we are so looking forward to welcoming back returning and commencing students to our campuses and communities.

We are very excited to share that NSW start welcoming back international students from December 2021 under a new NSW Government-approved, pilot returns program. The program will enable a small, but increasing number of returning international students to continue their Australian education, training and research on campus, in Australia. For more, please see the StudyNSW website.

As more information becomes available on the latest student returns plans, visas and vaccines, more details will be added here at the Study Australia website.